The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency
Open accessAbstract
Reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) involves a marked reorganization of chromatin. To identify post-translational histone modifications that change in global abundance during this process, we have applied a quantitative mass-spectrometry-based approach. We found that iPSCs, compared with both the starting fibroblasts and a late reprogramming intermediate (pre-iPSCs), are enriched for histone modifications associated with active chromatin, and depleted for marks of transcriptional elongation and a subset of repressive modifications including H3K9me2/me3. Dissecting the contribution of H3K9 methylation to reprogramming, we show that the H3K9 methyltransferases Ehmt1, Ehmt2 and Setdb1 regulate global H3K9me2/me3 levels and that their depletion increases iPSC formation from both fibroblasts and pre-iPSCs. Similarly, we find that inhibition of heterochromatin protein-1γ (Cbx3), a protein known to recognize H3K9 methylation, enhances reprogramming. Genome-wide location analysis revealed that Cbx3 predominantly binds active genes in both pre-iPSCs and pluripotent cells but with a strikingly different distribution: in pre-iPSCs, but not in embryonic stem cells, Cbx3 associates with active transcriptional start sites, suggesting a developmentally regulated role for Cbx3 in transcriptional activation. Despite largely non-overlapping functions and the predominant association of Cbx3 with active transcription, the H3K9 methyltransferases and Cbx3 both inhibit reprogramming by repressing the pluripotency factor Nanog. Together, our findings demonstrate that Cbx3 and H3K9 methylation restrict late reprogramming events, and suggest that a marked change in global chromatin character constitutes an epigenetic roadblock for reprogramming.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Peptide sequence and PTM data can also be obtained from specific sub-cellular fractions to profile, for example, the fascinating landscape of histone modifications, including simultaneous analysis of the co-occurrence of various combinations of histone marks41.”
From Decoding neuroproteomics: integrating the genome, translatome and functional anatomy (2014) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
Combinatorial patterns of histone acetylations and methylations in the human genome
Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Peng, W., Zhang, M. Q., et al. (2008) · Nature Genetics · doi:10.1038/ng.154 · Cited by 2,331
A unique chromatin signature uncovers early developmental enhancers in humans
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A., & Wysocka, J. (2011) · Nature · doi:10.1038/nature09692 · Cited by 2,233
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.04.014 · Cited by 1,072
Chin, M. H., Mason, M. J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.06.008 · Cited by 1,035
Self-citationNanog Is the Gateway to the Pluripotent Ground State
Silva, J., Nichols, J., Theunissen, T. W., Guo, G., van Oosten, A. L., Barrandon, O., Wray, J., Yamanaka, S., Chambers, I., & Smith, A. (2009) · Cell · doi:10.1016/j.cell.2009.07.039 · Cited by 1,031
Cited by
Items 101–200 of 220
Review Epigenetic mechanisms of induced pluripotency
Machnik, M., Andrzejewska, A., Oleksiewicz, U., & Estecio, M. R. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47135 · Cited by 24
“Repression of H3K9 methyltransferases (Ehmt2, Setdb1, Suv39h1/2) results in increased reprogramming efficiency, which is accompanied by decondensation of chromatin [67, 68].”
BackgroundCitrullination of HP1γ chromodomain affects association with chromatin
Wiese, M., Bannister, A. J., Basu, S., Boucher, W., Wohlfahrt, K., Christophorou, M. A., Nielsen, M. L., Klenerman, D., Laue, E. D., & Kouzarides, T. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0265-x · Cited by 24
“The Nanog gene may represent an important example of such a locus, since chromatin immunoprecipitation experiments have shown that both HP1γ and PADI4 bind to its promoter and regulate gene expression in stem cells [16, 22].”
InfluentialForsyth, R. G., Krenács, T., Athanasou, N. A., & Hogendoorn, P. C. W. (2021) · Cancers · doi:10.3390/cancers13205119 · Cited by 25
Martinez-Sarmiento, J. A., Cosma, M. P., & Lakadamyali, M. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114170 · Cited by 25
Affinity Purification of Methyllysine Proteome by Site-Specific Covalent Conjugation
Wang, R. Y., Huang, M. J., Li, L., Kaneko, T., Voss, C., Zhang, L. N., Xia, J., & Li, S. S. ‐. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b02796 · Cited by 22
Wille, C. K., & Sridharan, R. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.12.004 · Cited by 22
Self-citationElevated levels of ZAC1 disrupt neurogenesis and promote rapid in vivo reprogramming
Rraklli, V., Södersten, E., Nyman, U., Hagey, D. W., & Holmberg, J. (2015) · Stem Cell Research · doi:10.1016/j.scr.2015.11.002 · Cited by 23
“2G), all of which have been shown to act as barriers for acquisition of pluripotency (Zhao et al., 2008; Sridharan et al., 2013; Gaspar-Maia et al., 2013; Soufi et al., 2012; Pasque et al., 2012).”
BackgroundHP1γ regulates H3K36 methylation and pluripotency in embryonic stem cells
Zaidan, N. Z., & Sridharan, R. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1091 · Cited by 21
“As previously reported (5,55,56), the depletion of HP1 does not elicit a great change in the number or magnitude of gene expression, but there are more differentially upregulated genes compared to down (601 vs.”
BackgroundInfluentialSelf-citationEffect of BIX-01294 on H3K9me2 levels and the imprinted geneSnrpnin mouse embryonic fibroblast cells
Chen, P., Yao, J., Huang, R., Zheng, F., Jiang, X., Chen, X., Chen, J., Li, M., Huang, H., Yi-ping, J., et al. (2015) · Bioscience Reports · doi:10.1042/bsr20150064 · Cited by 21
Going up the hill: chromatin‐based barriers to epigenetic reprogramming
Arabacı, D. H., Terzioğlu, G., Bayırbaşı, B., & Önder, T. T. (2020) · FEBS Journal · doi:10.1111/febs.15628 · Cited by 21
Zhang, Y., Wang, Q., Liu, K., Gao, E., Guan, H., & Hou, J. (2018) · Cytotechnology · doi:10.1007/s10616-018-0224-6 · Cited by 20
Causal Gene Regulatory Network Modeling and Genomics: Second-Generation Challenges
Rothenberg, E. V. (2019) · Journal of Computational Biology · doi:10.1089/cmb.2019.0098 · Cited by 22
Tox4 modulates cell fate reprogramming
Vanheer, L., Song, J., Geest, N. D., Janiszewski, A., Talón, I., Provenzano, C., Oh, T., Chappell, J., & Pasque, V. (2019) · Journal of Cell Science · doi:10.1242/jcs.232223 · Cited by 27
“For reprogramming experiments, MEFs derived from Col1a1-tetO-OKSM (Plath), Rosa26-M2rtTA mice were used (Sridharan et al., 2013).”
BackgroundMethodInfluentialCarmona-Mora, P., Widagdo, J., Tomasetig, F., Canales, C. P., Cha, Y., Lee, W., Alshawaf, A. J., Dottori, M., Whan, R. M., Hardeman, E. C., et al. (2015) · Human Genetics · doi:10.1007/s00439-015-1591-0 · Cited by 26
Peñalosa-Ruiz, G., Bousgouni, V., Gerlach, J. P., Waarlo, S., van de Ven, J. V., Veenstra, T., Silva, J., van Heeringen, S. J., Bakal, C., Mulder, K. W., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.02.006 · Cited by 20
CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression
Zhang, P., Yang, X., Zha, Z., Zhu, Y., Zhang, G., & Li, G. (2022) · Cell Cycle · doi:10.1080/15384101.2022.2068329 · Cited by 19
“Epigenetic regulation can affect gene transcriptional activity by histone modification without changing DNA sequences [14].”
BackgroundConnecting the DOTs on Cell Identity
Wille, C. K., & Sridharan, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.906713 · Cited by 21
Self-citationRen, X., Zhuang, H., Jiang, F., Zhang, Y., & Zhou, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115343 · Cited by 19
Matsuura, T., Miyazaki, S., Miyazaki, T., Tashiro, F., & Miyazaki, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-12772-y · Cited by 21
Somatic Reprogramming—Above and Beyond Pluripotency
Meir, Y. J., & Li, G. (2021) · Cells · doi:10.3390/cells10112888 · Cited by 19
Eguchi, T., Csizmadia, E., Kawai, H., Sheta, M., Yoshida, K., Prince, T. L., Wegiel, B., & Calderwood, S. K. (2022) · Cells · doi:10.3390/cells11243993 · Cited by 22
“Moreover, HP1γ plays a critical role in reprogramming to pluripotency [80], which is involved in cancer stemness and the activation, inhibition and hybrid of EMT.”
BackgroundEnforcement of developmental lineage specificity by transcription factor Oct1
Shen, Z., Kang, J., Shakya, A., Tabaka, M., Jarboe, E. A., Regev, A., & Tantin, D. R. (2017) · eLife · doi:10.7554/elife.20937 · Cited by 21
“H3K9me2 also controls developmental gene induction (Wen et al., 2009; Zylicz et al., 2015) and reprogramming to pluripotency (Chen et al., 2013; Sridharan et al., 2013).”
BackgroundZane, L. K., Chapus, F., Pegoraro, G., & Misteli, T. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-12-0870 · Cited by 20
Roy, S., & Sridharan, R. (2017) · Genome Research · doi:10.1101/gr.215004.116 · Cited by 19
“27:1–13 Published by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/17; www.genome.org Genome Research 1 www.genome.org spectrometry approach (Sridharan et al. 2013).”
BackgroundMethodSelf-citationPeng, J., Zhang, W. J., Zhang, Q., Su, Y. H., & Tang, L. P. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1097780 · Cited by 18
“Indeed, H3K9 methyltransferases and Cbx3 were reported to repress the pluripotency gene NANOG to block reprogramming (Sridharan et al., 2013).”
BackgroundBernard, L. D., Dubois, A., Heurtier, V., Fischer, V., González, I., Chervova, A., Tachtsidi, A., Gil, N., Owens, N. D. L., Bates, L. E., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac550 · Cited by 19
Alternative Routes to Induced Pluripotent Stem Cells Revealed by Reprogramming of the Neural Lineage
Jackson, S. A., Olufs, Z. P. G., Tran, K. A., Zaidan, N. Z., & Sridharan, R. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.01.009 · Cited by 18
“These starting populations were derived from mice homozygous for the Yamanaka reprogramming factors Oct4, Klf4, Sox2, and c-Myc (OKSM) under the control of a doxycycline (dox) inducible promoter at a single locus and heterozygous for reverse tetracycline transactivator (rtta) ubiquitously expressed from the Rosa26 loc…”
BackgroundMethodSelf-citationTwo decades of induced pluripotent stem cell research: From discovery to diverse applications
Yamanaka, S. (2026) · Cell stem cell · doi:10.1016/j.stem.2026.02.003 · Cited by 21
DOT1L is a barrier to histone acetylation during reprogramming to pluripotency
Wille, C. K., Zhang, X., Haws, S. A., Denu, J. M., & Sridharan, R. (2023) · Science Advances · doi:10.1126/sciadv.adf3980 · Cited by 18
“ESCs also have a hyperacetylated epigenome ( 9 ) that enables their open chromatin structure.”
InfluentialSelf-citationManipulating cell fate through reprogramming: approaches and applications
Yagi, M., Horng, J. E., & Hochedlinger, K. (2024) · Development · doi:10.1242/dev.203090 · Cited by 17
Sirt6 regulates efficiency of mouse somatic reprogramming and maintenance of pluripotency
Xu, P., Wang, T., Liu, X., Wang, N.-Y., Sun, L.-H., Zhang, Z., Chen, H., Lv, X., Huang, Y., & Liu, D. (2019) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-1109-5 · Cited by 18
Lo, J. H.-H., Edwards, M., Langerman, J., Sridharan, R., Plath, K., & Smale, S. T. (2022) · Genes & Development · doi:10.1101/gad.350113.122 · Cited by 18
“(F ) Bar graphs showH3K27ac ChIP-qPCR levels at theZfp57 E3 and E4 regions inwild-type andmutant tetO-OSKM lines at each stage of differentiation and reprogramming.”
BackgroundMethodInfluentialSelf-citationNuclear-cytoplasmic shuttling of class IIa histone deacetylases regulates somatic cell reprogramming
Luo, Z., Qing, X., Benda, C., Huang, Z., Zhang, M., Huang, Y., Zhang, H., Wang, L., Lai, Y., Ward, C., et al. (2019) · Cell Regeneration · doi:10.1016/j.cr.2018.11.001 · Cited by 16
Autism-associated protein POGZ controls ESCs and ESC neural induction by association with esBAF
Sun, X., Cheng, L., & Sun, Y. (2022) · Molecular Autism · doi:10.1186/s13229-022-00502-9 · Cited by 20
Logie, C., & Knoch, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.71387 · Cited by 16
Targets of histone H3 lysine 9 methyltransferases
Levinsky, A. J., McEdwards, G., Sethna, N. S., & Currie, M. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1026406 · Cited by 18
“Suppressing H3K9 methyltransferases improves the efficiency of iPS cell generation by increasing the binding of Oct4 and Sox2 to these sites (Shi et al., 2008; Onder et al., 2012; Soufi et al., 2012; Sridharan et al., 2013).”
BackgroundBenevento, M., Tonge, P. D., Puri, M. C., Nagy, A., Heck, A. J. R., & Muñoz, J. (2015) · PROTEOMICS · doi:10.1002/pmic.201500031 · Cited by 15
“In the last couple of years, iPSCs and ESCs have been extensively characterized at the molecular level [9–11] and it has been shown that an “epigenetic memory” of the precursor cells might still be present in the derived iPSCs which can affect its differentiation potential [12,13].”
BackgroundMethodInfluentialMechanisms for enhancing cellular reprogramming
Soufi, A. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.007 · Cited by 14
Feng, Y., Zhao, X., Li, Z., Luo, C., Ruan, Z., Xu, J., Shen, P., Deng, Y., Jiang, J., Shi, D., et al. (2021) · Microscopy and Microanalysis · doi:10.1017/s1431927620024964 · Cited by 14
“Moreover, former results also revealed that the H3K9 methyltransferases could inhibit the reprogramming progress by repressing the pluripotency factor (Loh et al., 2007; Sridharan et al., 2013).”
ResultNde1 is required for heterochromatin compaction and stability in neocortical neurons
Chomiak, A. A., Guo, Y., Kopsidas, C. A., McDaniel, D. P., Lowe, C. C., Pan, H., Zhou, X., Zhou, Q., Doughty, M. L., & Feng, Y. (2022) · iScience · doi:10.1016/j.isci.2022.104354 · Cited by 16
“…of heterochromatin regions is fundamental to stem cell differentiation, and it reshapes the nuclear landscape to allow the spatial segregation of chromatin domains with distinctive transcription activities (Craig, 2005; Noma et al., 2001; Sridharan et al., 2013; Talbert and Henikoff, 2006).”
BackgroundSomatic Cell Reprogramming Informed by the Oocyte
González-Muñoz, E., & Cibelli, J. B. (2018) · Stem Cells and Development · doi:10.1089/scd.2018.0066 · Cited by 16
“H3K9me3-marked heterochromatin regions are considered epigenetic barriers for both SCNT and transcription factor reprogramming [96–101].”
Mechanism of chromatin segregation to the nuclear periphery in C. elegans embryos
Gonzalez‐Sandoval, A., & Gasser, S. M. (2016) · Worm · doi:10.1080/21624054.2016.1190900 · Cited by 14
Metabolism and Sex Differentiation in Animals from a Starvation Perspective
Sakae, Y., & Tanaka, M. (2021) · Sexual Development · doi:10.1159/000515281 · Cited by 13
Epigenetic preparation of future gene induction kinetics
Xiong, J., & Zhu, B. (2025) · Annual Review of Genetics · doi:10.1146/annurev-genet-012825-093148 · Cited by 12
The occurrence and development of induced pluripotent stem cells
Chen, Y., Li, M., & Wu, Y. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1389558 · Cited by 18
Serdyukova, K., Swearingen, A. R., Coradin, M., Nevo, M., Tran, H., Bajric, E., & Brumbaugh, J. (2023) · Development · doi:10.1242/dev.202169 · Cited by 14
Epigenetic regulation in stem cell development, cell fate conversion, and reprogramming
Ohbo, K., & Tomizawa, S.-I. (2015) · BioMolecular Concepts · doi:10.1515/bmc-2014-0036 · Cited by 13
Advances in stem cell proteomics
Abazova, N., & Krijgsveld, J. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.007 · Cited by 11
“Interestingly, the study demonstrates that heterochromatin protein-1g (CBX3), known to recognize H3K9 methylation, was only associated with active transcriptional start sites in pre-iPSCs, but not in fully pluripotent cells thus explaining why it is a roadblock to late reprogramming events [60].”
BackgroundKuno, A., Nishimura, K., & Takahashi, S. (2018) · BMC Genomics · doi:10.1186/s12864-017-4389-8 · Cited by 14
LncRNAs and Chromatin Modifications Pattern m6A Methylation at the Untranslated Regions of mRNAs
Vaasjo, L. O. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.866772 · Cited by 11
Systematic identification of gene family regulators in mouse and human embryonic stem cells
Aaronson, Y., Livyatan, I., Gokhman, D., & Meshorer, E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw259 · Cited by 12
“For example, condensin-II components were clustered alongside with many promoter related factors (19); the polycomb cluster displayed a very low correlation with the active expression cluster (H3K36me3 and RNA-seq tracks) but a high correlation with several promoter associated factors such as H3K4me3, consistent with…”
BackgroundTranscription factors specifically control changePreprint
Rothenberg, E. V. (2022) · Genes & Development · doi:10.1101/gad.350308.122 · Cited by 11
“As one key element, they have taken advantage of doxycycline-controllable induced pluripotent cells, developed by the group of Kathrin Plath (Sridharan et al. 2013).”
BackgroundHan, Y., Lu, C., Zhang, K., Tian, S., Fan, E., Chen, L., He, X., & Zhang, Y. (2015) · Analytical Methods · doi:10.1039/c5ay00120j · Cited by 10
[Continuous and intermittent infusion of vancomycin equally effective: review of the literature].
van Maarseveen, E. M., Man, W. H., Touw, D. J., Bouma, A., & van Zanten, A. R. H. (2011) · PubMed · Cited by 10
Epigenetic regulation of neural lineage elaboration: Implications for therapeutic reprogramming
Stricker, S. H., & Götz, M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105174 · Cited by 10
“…of the H3K9 de-methylases Jmjd2c and/or depletion of the H3K9 methyltransferases Ehmt1, G9a, Suv39h1, Suv39h2 and/or Setdb1 can increase rates of iPSC generation (Chen et al. 2013; Onder et al. 2012; Sridharan et al. 2013) or direct reprogramming e.g. into hepatocytes (Becker et al. 2017).”
BackgroundVidal, S. E., Polyzos, A., Chatterjee, K., Ee, L.-S., Swanzey, E., Morales-Valencia, J., Wang, H., Parikh, C. N., Amlani, B., Tu, S., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.08.011 · Cited by 10
“Chemical and genetic interference with EHMTs during OKSM-driven reprogramming of mouse neural progenitor cells (Shi et al., 2008) and fibroblasts (Sridharan et al., 2013) has been reported to facilitate iPSC formation, supporting the prevalent notion that H3K9 methyltransferase activity counteracts…”
BackgroundInfluentialWille, C. K., Neumann, E. N., Deshpande, A. J., & Sridharan, R. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.10.017 · Cited by 10
Self-citationCoordinated removal of repressive epigenetic modifications during induced reversal of cell identity
Tran, K. A., Dillingham, C. M., & Sridharan, R. (2019) · The EMBO Journal · doi:10.15252/embj.2019101681 · Cited by 12
“For pre-iPSCs (12-1 line) (Sridharan et al , 2013) carrying a Nanog-GFP reporter (Tran et al , 2015) reprogramming, cells were plated at 200,000 cells per well (6 well) on day 0 and treated with ascorbic acid (Sigma, A8960) (50 l g/ml), 2i: 1 l M PD-0325901 (Stemgent, 04-0006-10) and 3 l M…”
InfluentialSelf-citationZhang, D., Zhou, Y., Huang, R., Zhai, Y., Wu, D., An, X., Zhang, S., Shi, L., Li, Q., Kong, X., et al. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.971965 · Cited by 9
“Many studies have found that histone methylation has a crucial role in early embryonic development and pluripotency maintenance of stem cells (Boyer et al., 2006; Sridharan et al., 2013).”
BackgroundChen, P., Qian, Q., Zhu, Z., Shen, X., Yu, S., Yu, Z., Sun, R., Li, Y., Guo, D., & Fan, H. (2020) · Oncology Letters · doi:10.3892/ol.2020.11694 · Cited by 9
“H3K9 methylation is a crucial event in reprogramming to pluripotency (51).”
Heterochromatin and the molecular mechanisms of ‘parent-of-origin’ effects in animals
Singh, P. B. (2016) · Journal of Biosciences · doi:10.1007/s12038-016-9650-9 · Cited by 9
A Tale of Two States: Pluripotency Regulation of Telomeres
Novo, C. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703466 · Cited by 8
Effects and mechanism of arsenic trioxide in combination with rmhTRAIL in multiple myeloma
Zhou, H., Li, J., Jian, Y., Chen, T., Deng, H., Zhang, J., Zeng, H., Shan, Z., & Chen, W. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.10.004 · Cited by 7
Optical High Content Nanoscopy of Epigenetic Marks Decodes Phenotypic Divergence in Stem Cells
Kim, J. J., Bennett, N. K., Devita, M. S., Chahar, S., Viswanath, S. E., Lee, E. A., Jung, G., Shao, P. P., Childers, E. P., Liu, S., et al. (2017) · Scientific Reports · doi:10.1038/srep39406 · Cited by 7
Self-citationHuo, J. S., Baylin, S. B., & Zambidis, E. T. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.09.008 · Cited by 7
Chromatin, nuclear lamins, and maintenance of the differentiated identity
Bitman-Lotan, E., & Orian, A. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2018.07.005 · Cited by 7
Interplay between pioneer transcription factors and epigenetic modifiers in cell reprogramming
Mirizio, G. G., Sampson, S., & Iwafuchi, M. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.12.014 · Cited by 6
Transcriptomics and proteomics in stem cell research
Wang, H., Zhang, Q., & Fang, X. (2014) · Frontiers of Medicine · doi:10.1007/s11684-014-0336-0 · Cited by 6
Dynamic regulatory module networks for inference of cell type–specific transcriptional networksPreprint
Siahpirani, A. F., Knaack, S., Chasman, D. A., Seirup, M., Sridharan, R., Stewart, R. M., Thomson, J. L., & Roy, S. (2022) · Genome Research · doi:10.1101/gr.276542.121 · Cited by 6
“…and eight chromatin marks in three cellular stages: MEFs, pre-iPSCs, and iPSCs collected from multiple publications (Maherali et al. 2007; Sridharan et al. 2009, 2013; Roy and Sridharan 2017) (NCBI Gene Expression Omnibus [GEO; https://www.ncbi.nlm.nih.gov/geo/] accession number…”
Self-citationContreras‐Jurado, C., Montero‐Pedrazuela, A., Pérez, R. F., Alemany, S., Fraga, M. F., & Aranda, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1235614 · Cited by 5
Sperm and Spermatids Contain Different Proteins and Bind Distinct Egg Factors
Teperek, M., Miyamoto, K., Simeone, A., Feret, R., Deery, M. J., Gurdon, J. B., & Jullien, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916719 · Cited by 5
“This binding is important for the regulation of gene expression [55,56] and also for cell reprogramming to pluripotency [57].”
BackgroundTien, C., Mohammadparast, S., & Chang, C. (2021) · Developmental Dynamics · doi:10.1002/dvdy.319 · Cited by 5
“HP1γ deprivation is also shown to inhibit neural differentiation in mESC or render mESC poised to differentiate, and inactivation of HP1γ in adult cells promotes cell reprogramming to iPSC.(26,28,30) Overexpression of HP1γ in P19 embryonic carcinoma cells is sufficient to elicit spontaneous differentiation into all th…”
BackgroundYao, F., Hao, J., Wang, Z., Chu, M., Zhang, J., Xi, G., Zhang, Z., An, L., & Tian, J. (2023) · Genes · doi:10.3390/genes14040891 · Cited by 4
“Thus, post-fertilization removal of H3K9me3 is crucial for initiating ZGA and epigenetic reprogramming that confers developmental potential [34,35].”
BackgroundBiligiri, K. K., Sharma, N. R., Mohanty, A., Sarkar, D. P., Vemula, P. K., & Rampalli, S. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002871 · Cited by 4
“Such dramatic alterations are achieved by combinatorial efforts of several chromatin modifiers including EHMT1 [21,22].”
Resetting Cell Fate by Epigenetic Reprogramming
Wong, M. P. M., & Ng, R. K. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81015 · Cited by 4
Proteomics applications in next generation induced pluripotent stem cell models
Manda, V., Pavelka, J., & Lau, E. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2334033 · Cited by 2
“In another study, a label-free proteomics screen using DDA MS analysis found that repressive H3K9 marks impair reprogramming, and that active chromatin markers occur late in the pluripotency trajectory from pre-iPS to iPS cells [39].”
BackgroundRole of frustrations in cell reprogramming
Yao, Y., Zhu, J., Li, W., & Pei, D. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf303 · Cited by 3
“The fundamental principles of inducing protocols necessitate preparing epigenetic modifications, regularizing transcriptome of starting cells, and creating genetic status of targeted cells (46, 47).”
Scholz, B. A., Millán-Ariño, L., & Göndör, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803395-1.00017-4 · Cited by 2
Tani, T., & Kato, Y. (2017) · Cellular Reprogramming · doi:10.1089/cell.2016.0044 · Cited by 3
“Recently, a number of researchers have examined the mechanism of transcription factor-mediated reprogramming by whole-genome analysis (Apostolou and Hochedlinger, 2013; Soufi et al., 2015; Sridharan et al., 2013).”
Reprogramming cell fates towards novel cancer immunotherapies
Leung, E. H. W., Joves, K., Petenkaya, A., Barham, G., Henderson, T. G., Liang, J., & Chronis, C. (2022) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2022.102312 · Cited by 2
Self-citationUncovering the significance of CBX3 as an up-and-coming biomarker in cardio-vascular health
Wahab, M. A., Gaudio, N. D., Gargiulo, B., Quagliariello, V., Maurea, N., Grieco, M., Benedetti, R., Nebbioso, A., Altucci, L., & Conte, M. (2025) · Epigenetics Communications · doi:10.1186/s43682-024-00032-w · Cited by 1
HP1β and H3K9me3 Regulate Olfactory Receptor Choice and Transcriptional Identity
Escamilla-Del-Arenal, M., Duffié, R., Shayya, H. J., Loconte, V., Ekman, A. A., Street, L. A., Horta, A., Canzio, D., Monahan, K., Larabell, C., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072958 · Cited by 3
Hnízda, A., Martínez–Delgado, B., Sánchez-Ponce, D., Alonso, J., Amiel, J., Attié‐Bitach, T., Bada-Navarro, A., Baladrón, B., Bermejo, E., Brinsa, V., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74987-w · Cited by 3
Tomizawa, S.-I., Shirakawa, T., & Ohbo, K. (2014) · Current Pathobiology Reports · doi:10.1007/s40139-013-0038-3 · Cited by 1
Epigenetic effects induced by the ectopic expression of Pax7 in 3T3-L1
Elgaabari, A., Miyawaki‐Kuwakado, A., Tomimatsu, K., Wu, Q., Tokunaga, K., Izumi, W., Suzuki, T., Tatsumi, R., & Nakamura, M. (2021) · The Journal of Biochemistry · doi:10.1093/jb/mvab030 · Cited by 2
Chromatin plasticity in pluripotent and cancer stem cells
Biran, A., & Meshorer, E. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814085-7.00009-x · Cited by 1
On the relation of phase separation and Hi-C maps to epigeneticsPreprint
Singh, P. B., & Newman, A. G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/814566 · Cited by 1
“Mouse NK SETDB1 [ 115,240 ] [ 115,240,241 ] NK NK HP1γ [ 241 ] NK NK NK NK NK NK NK”
Nde1 is Required for Heterochromatin Compaction and Stability in Neocortical NeuronsPreprint
Chomiak, A. A., Lowe, C. C., Guo, Y., McDaniel, D., Pan, H., Zhou, X., Zhou, Q., Doughty, M. L., & Feng, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.25.449848 · Cited by 1
Bernard, L. D., Dubois, A., Heurtier, V., Chervova, A., Tachtsidi, A., Gil, N., Owens, N. D. L., Vandormael‐Pournin, S., Ulitsky, I., Cohen‐Tannoudji, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.07.459323 · Cited by 1
Epigenetics, Stem Cell Pluripotency and Differentiation
Barrero, M. J. (2015) · Wiley eBooks · doi:10.1002/9781118670613.ch2
Serine, threonine and tyrosine o-acetylation in the chromatin landscape
Britton, L.-M. P. (2014) · Cited by 1
Respuela, P., & Rada-Iglesias, Á. (2016) · Current Stem Cell Reports · doi:10.1007/s40778-016-0050-8 · Cited by 1
Epigenetic Regulation of ES Cell Pluripotency Maintenance
Hu, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-25325-1_9
Epigenetics: the guardian of pluripotency and differentiation
Machnik, M., Nijak, A., Paula, L. O. T. A., & Oleksiewicz, U. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1509-30
“The retention of H3K9me3 in cells undergoing reprogramming blocks the transition from the pre-iPSC to iPSC stage (Chen et al., 2013; Sridharan et al., 2013).”
BackgroundEpigenetic Regulations in Cardiac Development
Xin, M., & Song, K. (2016) · Cardiac and vascular biology · doi:10.1007/978-3-319-41457-7_3
The Role of UPF3B in Pluripotency and Differentiation
Shao, A. (2015) · eScholarship (California Digital Library)
Smolko, A. E., Shapiro-Kulnane, L., & Salz, H. K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/259473
Novel Approaches for Pluripotent Reprogramming
Weltner, J. (2018) · Työväentutkimus Vuosikirja · Cited by 1
H3K9 trimethylation controls oncogenic signaling and the malignant state in mantle cell lymphoma
Hajmirza, A. (2017) · theses.fr (ABES) · doi:10.70675/0898eb39z5d87z4403z812az283e622465f0
Sex differences in gene expression and proliferation are dependent on the epigenetic modifier HP1γPreprint
Law, P. P., Chan, P., McEwen, K. R., Zhi, H., Liang, B., Naruse, C., Asano, M., Tan-Un, K., Chan, G., & Festenstein, R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/563940
Metadata
- Authors
- Sridharan, R., Gonzales-Cope, M., Chronis, C., Bonora, G., McKee, R., Huang, C., Patel, S., Lopez, D., Mishra, N., Pellegrini, M., Carey, M., Garcia, B. A., & Plath, K.
- Affiliations
- University of California, Los Angeles (US)
- University of Pennsylvania (US)
- Wake Forest University Health Sciences (US)
- Corresponding author
- Garcia, Benjamin A.
- Plath, Kathrin
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2013-06-09
- Volume
- 15
- Issue
- 7
- Pages
- 872-882
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC3733997
- OpenAlex
- W1980909928
- Cited by
- 220
- References
- 54
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 10 · 2023: 12 · 2022: 17 · 2021: 19 · 2020: 15 · 2019: 27 · 2018: 20 · 2017: 24 · 2016: 20 · 2015: 26 · 2014: 16 · 2013: 1
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Blood Cancer UK (10040)
- National Institutes of Health (DP2OD007447, 1dp2od001686-01)
- National Human Genome Research Institute (T32HG002536)
- National Institute of General Medical Sciences (P01GM081621, P01GM099134, GM074701, R25GM055052, R01GM074701)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- induced pluripotent stem cells, cellular reprogramming, H3K9 methylation, CBX3, H3K9 methyltransferase, EHMT1, G9a, SETDB1, histone modifications, chromatin reorganization, Nanog, transcriptional activation, fibroblasts
- MeSH terms
- Nanog Homeobox Protein, Animals, Cells, Cultured, Chromatin, Chromosomal Proteins, Non-Histone, Embryo, Mammalian, Female, Fibroblasts, Histones, Male, Histone-Lysine N-Methyltransferase, Protein Processing, Post-Translational, Homeodomain Proteins, Gene Expression Regulation, Developmental, DNA Methylation, Genomics, Transcription Initiation Site, Proteomics, Epigenesis, Genetic, Chromatin Immunoprecipitation, Mice, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.